Brent Gardner brings 20 years of leadership experience in the pharmaceutical industry to AVEO in his role as Executive Director, Medical Affairs. Prior to joining AVEO, Brent served as Executive Director, Medical Affairs at Epizyme where he led the field medical affairs organization as well as the investigator-sponsored research program, real-world evidence research program and the expanded access program. Prior to Epizyme, Brent built and led the medical affairs function at Partner Therapeutics, having broad responsibility for external stakeholder engagement, publications, evidence generation, medical education and medical information. Brent has also served in various medical affairs roles at Algeta, Bayer, Biodesix and Merrimack Pharmaceuticals. Brent began his career leading a radiopharmacy teams for Covidien, Triad Isotopes and IBA Molecular. Brent holds a Doctor of Pharmacy degree from Purdue University.